Recipient of federal assistance · ANN ARBOR, MI

GENETOBE INC

GENETOBE INC received -$105.2K in federal grants and other assistance in FY2026, on 4 actions. It has no federal contracts in the loaded years. Since FY2022: $3M.

Assistance · FY2026
-$105.2K
New awards
0
Actions
4
Since FY2022
$3M
UEI
FXRCJNY4PJL1
Location
ANN ARBOR, MI
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 246.1KFY2022
  2. 1.3MFY2023
  3. 1.6MFY2024
  4. 0FY2025
  5. -105.2KFY2026

By type

  1. Grants-$105.2K0.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research-$3,0340.0%
  2. 93.172 · Human Genome Research-$18.1K0.0%
  3. 93.859 · Biomedical Research and Research Training-$35.7K0.0%
  4. 93.273 · Alcohol Research Programs-$48.4K0.0%

Largest awards

  1. A PRECISION MEDICINE FOR ALCOHOL-ASSOCIATED LIVER DISEASE - ABSTRACT THE GOAL OF THIS STUDY IS TO DEVELOP AN RNAI-BASED GENETIC PRECISION…$1.9M
    93.273 · Alcohol Research Programs· National Institutes of Health· Cooperative agreement· Sep 20, 2023 – Jan 15, 2026· UT2AA031151
  2. NOVEL SELECTIVE SGLT-1 INHIBITORS FOR ADJUNCTIVE THERAPY FOR CYSTIC FIBROSIS ASSOCIATED METABOLIC DISEASES - PROJECT SUMMARY CF ASSOCIATED…$303.7K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 6, 2024 – Mar 4, 2026· R42DK141338
  3. GENOME EDITING THERAPY FOR USHER SYNDROME TYPE 3 - PROJECT SUMMARY/ABSTRACT USHER SYNDROME TYPE 3A (USH3A), AN AUTOSOMAL RECESSIVE…$271.8K
    93.172 · Human Genome Research· National Institutes of Health· Project grant· Aug 31, 2023 – Apr 23, 2026· R42EY035582
  4. DEVELOPING NOVEL TYPE 1 CRISPR TOOLS FOR GENE EDITING THERAPY - ABSTRACT/PROJECT SUMMARY GENE EDITING THERAPY USING THE NOBEL PRIZE…$257.7K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Feb 15, 2024 – Jun 16, 2026· R41GM153041

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2022–FY2026.